Gene Query: MANSC1

Dataset Description Geneva Score
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 22.89
Identifying the molecular mode of action of itraconazole in colorectal cancer 21.89
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 21.1
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 19.59
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 18.77
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 17.31
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 17.19
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 16.34
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 16.34
RNA-Seq in neutrophils from Antiphospholipid Syndrome 15.29
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 15.15
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 14.07
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 13.92
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 13.68
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 13.25
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 12.38
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 12.14
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 12.05
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 12.05
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 11.71
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 11.56
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 11.5
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 11.03
Transcriptome of EBV-infected gastric cancer cell lines 10.73
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 10.65
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 10.6
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 10.0
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 9.99
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 9.97
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 9.92
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 9.6
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 9.55
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 9.45
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 9.35
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 9.29
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 9.22
RNA-seq of tumor cells following angiopellosis extravasation 9.21
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 9.13
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 8.8
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 8.75
LNCaP treated with iBET 8.72
Dysregulated immune system networks in war veterans with PTSD 8.63
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 8.52
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 8.34
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 8.33
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 8.22
Identification of Nrf2 regulated genes by RNA sequencing 8.08
Nrf2 regulated genes in A549 cells 8.08
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 8.0
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 7.93
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 7.93
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 7.9
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 7.84
Effect of from Human Umbilical Vein Endothelial Cells 7.82
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 7.71
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 7.61
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 7.52
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 7.46
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 7.46
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 7.43
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 7.36
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 7.18
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 7.13
Gene expression alterations of pancreatic intraepithlial neoplasia 7.09
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 7.06
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 6.99
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 6.89
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 6.87
RNA m5C Methylation in breast cancer using MeRIP-Seq 6.77
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 6.7
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 6.6
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 6.45
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 6.43
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 6.38
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 6.1
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 6.07
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 6.07
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 5.98
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 5.92
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 5.81
Morphological and molecular characterization of human dermal lymphatic collectors 5.7
AR-independent prostate cancer is sustained through FGF signaling 5.69
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 5.63
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 5.5
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 5.39
RNAseq of IL-36 stimulated primary human keratinocytes 5.3
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 5.23
Capturing the Interactome of Newly Transcribed RNA 5.22
Capturing the Interactome of Newly Transcribed RNA (RICK) 5.22
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 5.19
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 5.14
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 5.1
Dtx3L and Androgen Signaling in Prostate Cancer 5.03
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 5.03
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 4.94
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 4.94
Transcriptional effect of ETV1 knockdown in melanoma cells 4.94
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 4.91
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 4.78
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 4.75
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 4.74
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 4.73
HNF1A deficiency impairs β-cell fate, granule maturation and function 4.63
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 4.62
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 4.62
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 4.52
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 4.51
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 4.51
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 4.44
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 4.44
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 4.4
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 4.38
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 4.35
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 4.34
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 4.34
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 4.32
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 4.28
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 4.27
Silencing p300 in MCF7 cells to study expression and alternative splicing 4.25
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 4.21
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 4.19
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 4.19
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 4.18
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 4.18
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 4.18
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 4.18
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 4.16
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 4.16
Selective expression of long non-coding RNAs in a breast cancer cell progression model 4.13
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 4.09
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 4.09
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 4.08
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 4.08
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 4.08
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 4.08
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 4.06
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 4.06
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 4.0
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 3.89
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 3.86
Transcriptomic analyssis following EHMT1/2 inhibition 3.86
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 3.85
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 3.84
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 3.84
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 3.82
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 3.81
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 3.79
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 3.76
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 3.76
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 3.75
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.73
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 3.71
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 3.71
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 3.7
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 3.68
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 3.68
BAF controls genome accessibility 3.65
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 3.63
Transcriptional profiling of LS1034 cells treated with tepoxalin 3.62
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 3.6
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 3.58
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 3.58
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 3.56
Discovering human diabetes-risk gene function with genetics and physiological assays 3.55
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 3.55
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 3.54
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 3.53
Chromatin-informed inference of transcriptional programs in gynecologic cancers 3.53
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 3.53
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 3.5
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 3.46
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 3.39
Gene expression analysis of dengue-infected cells 3.38
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 3.37
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 3.36
Investigation about fibroblasts of different origins in culture 3.36
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 3.33
Total RNA sequencing of WT intestinal orgaonids. 3.32
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 3.32
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 3.32
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 3.29
Role of COP1 on MAP kinase transcriptional output in melanoma 3.26
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 3.24
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 3.22
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 3.22
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 3.21
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 3.13
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 3.13
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 3.11
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 3.11
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 3.1
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 3.09
A prostate cancer chromatin interaction map 3.06
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 3.06
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 3.04
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.02
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 3.0
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 2.98
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 2.96
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 2.96
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 2.96
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 2.94
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 2.94
Exploring the RNA landscape of endothelial exosomes 2.93
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 2.92
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 2.9
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 2.87
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 2.87
The Genomic Landscape of Atypical Fibroxanthoma 2.86
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 2.84
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 2.84
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 2.84
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 2.81
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 2.8
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 2.8
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 2.79
Differentiation enhances Zika virus infection in neuronal brain cells 2.78
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 2.75
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 2.75
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 2.74
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 2.74
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 2.74
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 2.74
miR-93 Targets in Human Endothelial Cells 2.73
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 2.71
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 2.71
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 2.69
IRF2 is a master regulator of human keratinocyte stem cell fate 2.69
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 2.68
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 2.68
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 2.68
Selective suppression of endothelial cytokine production by progesterone receptor 2.68
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 2.68
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 2.65
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 2.65
Human neutrophil genome during PMA- and E. coli encounter-induced activation 2.65
STX4 Over-Expression in Human islets 2.65
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 2.65
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 2.64
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 2.64
Dermal endothelial cells of type 2 diabetic patients 2.64
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 2.64
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 2.63
Genome wide expression change by RNF168 knocking down in MCF-7 cells 2.62
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 2.61
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 2.58
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.58
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 2.58
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 2.58
Gene expression profile difference among renal location in a stone former 2.58
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 2.55
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 2.55
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 2.54
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 2.53
RNA-seq differential expression studies: more sequence, or more replication? 2.53
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 2.51
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 2.51
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 2.5
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.49
Nutritional control of protein translation 2.49
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 2.49
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 2.47
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 2.47
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 2.46
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 2.46
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 2.44
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 2.43
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 2.42
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 2.42
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 2.41
Gene expression profiling in metabolically heterogeneous human lung tumors 2.39
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 2.38
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 2.35
TT-Seq captures the human transient transcriptome 2.34
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 2.33
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 2.33
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 2.32
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 2.29
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 2.29
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 2.28
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 2.27
RNA-Seq and expression data from human adipose tissue 2.27
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.27
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 2.24
Single-cell analysis of adult human ovary using 10X genomics 2.24
Tpl-2 small molecule project 2.22
Tpl-2 and MEK small molecule inhibitors 2.22
Effect of CHKA knockdown on C4-2 cell transcriptome 2.22
Reassessment of Exosome Composition 2.21
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 2.18
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 2.16
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 2.15
Effect of PBK knockdown on C4-2 cell transcriptome 2.14
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 2.08
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 2.07
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 2.06
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 2.06
Effect of Hotair overexpression in human breast cancer cell lines 1.95
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 1.93
Changes in human endometrial gland transcriptome over the window of implantation 1.92
Overexpression and knockdown experiment for circCSNK1G3 1.91
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 1.91
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 1.88
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 1.87
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 1.86
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 1.85
LIN28A modulates splicing and gene expression programs in breast cancer cells 1.85
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 1.85
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.85
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 1.82
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 1.81
Total RNA sequencing of APC mutant and wt colonic organoids 1.78
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 1.77
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 1.74
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 1.73
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 1.73
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 1.72
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 1.72
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.71
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.7
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.69
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 1.68
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 1.66
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 1.65
Identification of HOXB13 target genes responsive to BET inhibitors 1.64
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.63
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.63
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 1.62
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 1.62
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 1.62
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.6
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 1.59
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 1.58
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 1.58
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 1.57
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 1.57
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 1.55
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 1.55
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.53
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.52
Reprogrammed myeloid cell transcriptomes in NSCLC 1.49
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 1.47
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 1.47
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 1.46
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 1.45
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 1.41
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 1.41
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 1.4
mRNA sequencing of oropharyngeal cancer cell lines 1.37
Transcriptome sequencing of K-562 cells 1.36
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.35
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.35
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.34
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 1.33
RNA sequencing of human pancreatic cancer cell lines 1.33
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 1.3
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 1.3
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 1.3
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 1.3
RNA-Seq with and without RNase treatment in PCa cell lines 1.28
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 1.26
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 1.26
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.25
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 1.24
Transposon-based construction of strand-specific RNA-seq libraries 1.23
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 1.22
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 1.22
The role of CFTR in islet function 1.21
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 1.21
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.19
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 1.19
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 1.15
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 1.14
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 1.14
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 1.14
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 1.13
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.13
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.13
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 1.11
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 1.11
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 1.1
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.1
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 1.08
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 1.08
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.08
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 1.04
Loss of endometrial plasticity in recurrent pregnancy loss 1.04
The effect of Abl kinases on non-small cell carcinoma global transcriptome 0.97
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.96
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.96
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.95
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 0.95
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.94
Regulation of hypoxia-inducible factor activity by ZMYND8 0.94
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 0.94
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 0.92
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 0.92
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 0.9
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 0.9
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.87
Gene expression analysis of human adenomas. 0.87
The gene expression profiles of gallbladder cancer 0.85
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.84
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.82
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.82
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.8
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.8
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.8
FOXP2's impact on the primate transcriptome 0.79
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 0.78
Copper Regulation of HIF-1 Transcription Activity 0.78
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.77
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.77
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.75
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 0.75
Generation of KRAS signatures using immortalized isogenic lung cells. 0.74
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 0.72
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.71
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.71
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 0.71
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.64
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.64
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.63
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 0.63
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 0.63
Transcriptomes in healthy and CHB fetal hearts 0.62
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 0.61
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.6
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 0.59
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 0.59
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.59
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.58
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 0.58
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 0.58
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.57
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.57
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 0.57
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 0.56
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.56
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 0.55
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.54
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.53
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 0.52
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.52
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 0.51
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 0.49
ML29755 RNA-seq data 0.47
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.46
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.45
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.45
RNA-seq of primary patient AML samples 0.43
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.43
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 0.42
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.42
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.41
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 0.39
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.38
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.35
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.35
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 0.32
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 0.32
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.32
Identification of a LIF-responsive replication-competent human β cell 0.31
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.27
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.27
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.25
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.25
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.23
Preclinical model of obesity and ER-positive breast cancer 0.22
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.21
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 0.21
Gene expression profile of CRC-derived HILEC 0.2
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.2
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 0.18
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.16
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.16
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.16
A single-cell transcriptome atlas of the human pancreas 0.15
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 0.15
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 0.15
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.14
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 0.14
Androgen Receptor-regulated genes in prostate cancer cells 0.14
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 0.13
Defective structural RNA processing in relapsing-remitting multiple sclerosis 0.12
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.12
The transcriptome and chromatin accessbility landscape of mammalian germline 0.11
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.1
RNA seq analysis of human Fetal and adult derived Enterospheres 0.08
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.07
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.07
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.07
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.06
Expression analysis of the TAF1 syndrome 0.05
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.05
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.05
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.03
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 0.02
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.01
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation